Earnings Tailwind — ER in 17.234d · w1 med 6.0% (mag 3/3) · winRate 64.5% (rel 2/3) · n31
About Guardant Health Inc
Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally. The company offers Guardant360 CDx test, a liquid biopsy test for tumor mutation profiling; Guardant360 Liquid test, which measures 740+ genes and supports all guideline-recommended biomarkers; Guardant Reveal test, a blood test that utilizes circulating tumor DNA to detect cancer at the molecular level; an… Read full Trend Edge analysis →
Sector: Healthcare
Industry: Diagnostics & Research
Exchange: NASDAQ
IPO Date: October 4, 2018
Headquarters: 3100 Hanover Street, Palo Alto, CA, United States, 94304
Founder-Led: Yes — Helmy Eltoukhy (Co-Chief Executive Officer and Chairman), AmirAli Talasaz (Co-Chief Executive Officer and Director)
Key Metrics
Current Price
$160.05
Market Cap
$21.76B
Float
127.8M
Shares Outstanding
132.6M
Price/Sales (TTM)
20.14
vs. Analyst Target
-4.7% to analyst PT
Profit Margin
-40.10%
Operating Margin (TTM)
-40.23%
Revenue (TTM)
$1.08B
Dividend Rate
None
Analyst Target Price
$152.54 (23 analysts)
Financial History
Annual Revenue & Earnings History
Year
Revenue
Net Income
Gross Profit
EBITDA
2020
$287M
-$254M
$194M
-$225M
2021
$374M
-$406M
$251M
-$360M
2022
$450M
-$655M
$293M
-$615M
2023
$564M
-$479M
$337M
-$433M
2024
$739M
-$436M
$449M
-$390M
2025
$982M
-$416M
$633M
-$374M
Recent Quarterly Revenue & Net Income
Quarter
Revenue
Net Income
Jun 2025
$232M
-$99.9M
Sep 2025
$265M
-$92.7M
Dec 2025
$281M
-$128M
Mar 2026
$302M
-$112M
Ownership & Float
Insider Ownership
4.0%
Institutional Ownership
106.0%
Short Float
10.2%
% of All Funds Holding
5.50%
Number of Funds Holding
452
Current Moving Averages
Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.
Timeframe
SMA
Value
Trend Context
Weekly
10-Week SMA
$130.55
Near-term / short-term trend
Weekly
40-Week SMA
$103.86
Medium-term trend
Weekly
80-Week SMA
$75.75
Cyclical trend (business cycle)
Weekly
200-Week SMA
$48.30
Secular trend (multi-year)
Monthly
10-Month SMA
$113.07
Near-term monthly trend
Monthly
20-Month SMA
$80.21
Medium-term monthly trend
Monthly
40-Month SMA
$53.86
Secular monthly trend
Volume Shelves — Support & Resistance
Trend Edge identifies volume shelves: price zones where historically elevated trading volume
creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative
volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.
Price Level
Type
Volume Ratio
Age
$63.00
support
1.16x
8 months ago
$41.00
support
1.25x
10 months ago
$31.30
support
1.15x
17 months ago
$22.30
support
1.08x
19 months ago
$18.10
support
1.50x
25 months ago
Historical Earnings Reactions (31 events)
Timeframe
Avg Return
Median
Win Rate
Best
Worst
Gap
3.00%
0.12%
51.61%
28.07%
-7.91%
1 Day
3.84%
3.47%
61.29%
27.87%
-22.48%
1 Week
4.68%
6.05%
64.52%
33.18%
-29.20%
2 Weeks
5.39%
4.14%
54.84%
37.12%
-27.50%
1 Month
7.46%
1.46%
53.33%
63.79%
-24.00%
Next earnings: July 29, 2026 (17 days away)
Seasonality & Day-of-Week Patterns
Monthly Seasonality
Month
Avg Return
Win Rate
Samples
Jan
7.1%
62.5%
8
Feb
3.4%
25.0%
8
Mar
-2.3%
50.0%
8
Apr
-2.3%
37.5%
8
May
11.8%
62.5%
8
Jun
9.1%
75.0%
8
Jul
5.1%
71.4%
7
Aug
8.3%
57.1%
7
Sep
-6.6%
28.6%
7
Oct
3.0%
28.6%
7
Nov
13.0%
75.0%
8
Dec
-6.6%
50.0%
8
Day-of-Week Tendencies
Day
Avg Return
Win Rate
Samples
Monday
-0.17%
48.9%
366
Tuesday
0.17%
50.1%
401
Wednesday
0.39%
49.0%
398
Thursday
0.40%
51.3%
390
Friday
0.07%
49.2%
390
Top Institutional Holders
Institutional holder breakdown coming soon.
Total institutional ownership: 106.0%
Insider Transactions — Smart Summary
Total insider ownership: 4.0%
Founder-led management: Helmy Eltoukhy (Co-Chief Executive Officer and Chairman), AmirAli Talasaz (Co-Chief Executive Officer and Director)
Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Guardant Health Inc
(GH) powered by Claude Opus — Anthropic's most capable AI model.
The analysis covers five layers:
technical analysis (near-term, medium-term, cyclical, and secular trend, momentum,
volume shelf support and resistance, breakout and breakdown signals),
qualitative analysis (business model, competitive moat, sector dynamics),
insider sentiment (buy and sell signals from executive and director transactions),
share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and
fundamental analysis (valuation, revenue growth, profit margin, earnings quality).
AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit,
stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward.
Whether you are building a long position, initiating a short, or looking for a reversal setup,
AI Consult identifies the highest-probability signal from the current trend.